{"id":"vaccine-without-gelatin","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (pain, redness, swelling)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Vaccines work by presenting antigens to the immune system to generate protective antibody and cellular immune responses. This particular vaccine is manufactured without gelatin, which is commonly used as a stabilizer in many vaccine formulations. The gelatin-free formulation maintains immunogenicity while accommodating patients who cannot receive gelatin-containing vaccines due to allergies, veganism, or religious observance.","oneSentence":"A vaccine formulation that stimulates immune response without using gelatin as an excipient, making it suitable for patients with gelatin allergies or religious/dietary restrictions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:38:57.698Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Infectious disease prevention (specific pathogen not specified in available information)"}]},"trialDetails":[{"nctId":"NCT05801978","phase":"PHASE4","title":"Durability of Vaccine Responses","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-04-11","conditions":"Vaccine Response","enrollment":66},{"nctId":"NCT01638403","phase":"PHASE3","title":"Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.","status":"COMPLETED","sponsor":"Bioprojet","startDate":"2010-11","conditions":"Treatment of Excessive Daytime Sleepiness in Narcolepsy","enrollment":180},{"nctId":"NCT01684072","phase":"PHASE4","title":"Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin","status":"COMPLETED","sponsor":"Beijing Center for Disease Control and Prevention","startDate":"2011-01","conditions":"Chickenpox, Zoster","enrollment":1200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":324,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"vaccine without gelatin","genericName":"vaccine without gelatin","companyName":"Beijing Center for Disease Control and Prevention","companyId":"beijing-center-for-disease-control-and-prevention","modality":"Biologic","firstApprovalDate":"","aiSummary":"A vaccine formulation that stimulates immune response without using gelatin as an excipient, making it suitable for patients with gelatin allergies or religious/dietary restrictions. Used for Infectious disease prevention (specific pathogen not specified in available information).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}